Compounds > technetium tc 99m sestamibi
Page last updated: 2024-08-16

technetium tc 99m sestamibi and Cystosarcoma Phyllodes

technetium tc 99m sestamibi has been researched along with Cystosarcoma Phyllodes in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (50.00)18.2507
2000's3 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Koutsikos, J; Lazaris, D; Mainta, E; Papantoniou, V; Sotiropoulou, M; Tsiouris, S; Zerva, C1
Awane, H; Irie, K; Kitai, T; Komibuchi, T; Nishio, T; Ohta, H; Shintaku, M; Ukikusa, M; Yamamoto, S1
Chan, YL; King, W; Lam, WW; Metreweli, C; Stewart, IE; Yang, WT1
Awane, H; Irie, K; Ohta, H; Shintaku, M; Ukikusa, M; Yamamoto, S1
Abad, L; Castellón, I; Fuentes, T; Illana, J; Mulero, F; Nicolás, F; Nuño de la Rosa, JA; Roca, V1
Christodoulidou, J; Feida, H; Louvrou, A; Michalas, S; Pampouras, G; Papadaki, E; Papantoniou, V; Sotiropoulou, M; Souvatzoglou, M; Valotassiou, V; Zerva, C1

Other Studies

6 other study(ies) available for technetium tc 99m sestamibi and Cystosarcoma Phyllodes

ArticleYear
Scintimammographic findings of phyllodes tumor of the breast in a double-phase study with Tc-99m (V)DMSA and Tc-99m MIBI: a case report.
    Japanese journal of clinical oncology, 2004, Volume: 34, Issue:7

    Topics: Aged; Breast Neoplasms; Female; Humans; Mammography; Neoplasm Recurrence, Local; Phyllodes Tumor; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Dimercaptosuccinic Acid; Technetium Tc 99m Sestamibi

2004
Technetium-99m-sestamibi scintimammography of benign and malignant phyllodes tumors.
    Annals of nuclear medicine, 1997, Volume: 11, Issue:1

    Topics: Breast Neoplasms; Female; Humans; Middle Aged; Phyllodes Tumor; Radionuclide Imaging; Technetium Tc 99m Sestamibi

1997
Role of MIBI breast scintigraphy in evaluation of palpable breast lesions.
    The British journal of radiology, 1996, Volume: 69, Issue:828

    Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Carcinoma; Contrast Media; Female; Fibroadenoma; Humans; Mammography; Middle Aged; Phyllodes Tumor; Prospective Studies; Radionuclide Imaging; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Ultrasonography, Mammary

1996
Tc-99m sestamibi and Tc-99m HMDP uptake in a malignant phyllodes tumor of the breast.
    Clinical nuclear medicine, 1997, Volume: 22, Issue:8

    Topics: Breast Neoplasms; Female; Humans; Middle Aged; Phyllodes Tumor; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Medronate; Technetium Tc 99m Sestamibi

1997
[Usefulness of quantification and visual analysis of the uptake of (99m)Tc-MIBI in the diagnosis of mammary lesions].
    Revista espanola de medicina nuclear, 2000, Volume: 19, Issue:3

    Topics: Algorithms; Breast; Breast Diseases; Breast Neoplasms; Carcinoma; Diagnosis, Differential; False Negative Reactions; False Positive Reactions; Female; Fibroadenoma; Humans; Phyllodes Tumor; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Single-Blind Method; Technetium Tc 99m Sestamibi

2000
Uptake and washout of 99mTcV-dimercaptosuccinic acid and 99mTc-sestamibi in the assessment of histological type and grade in breast cancer.
    Nuclear medicine communications, 2002, Volume: 23, Issue:5

    Topics: Adenocarcinoma; Adult; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Intraductal, Noninfiltrating; Carcinoma, Lobular; False Negative Reactions; Female; Humans; Mammography; Neoplasm Staging; Neoplasms, Ductal, Lobular, and Medullary; Phyllodes Tumor; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Technetium Tc 99m Dimercaptosuccinic Acid; Technetium Tc 99m Sestamibi

2002